Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 3
2019 4
2020 15
2021 16
2022 10
2023 15
2024 12
2025 14
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML.
Borate UM, Huang Y, Lin TL, Handa S, Swords R, Lachowiez CA, Traer E, Stock W, Odenike O, Patel AA, Baer MR, Duong VH, Stein EM, Blum W, Vale CA, Curran E, Madanat YF, Olin RL, Schiller GJ, Nichols AD, Williams L, Heerema NA, Johnson MF, Chen TL, Marcus S, Martycz M, Stefanos M, Rosenberg L, DeGennaro LJ, Gruenbaum L, Burd A, Byrd JC, Druker BJ, Levine RL, Yocum AO, Mims AS, Zeidner JF. Borate UM, et al. Among authors: mims as. Blood. 2026 Jul 28:blood.2026034611. doi: 10.1182/blood.2026034611. Online ahead of print. Blood. 2026. PMID: 42520193
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.
Hoff FW, Zeidner JF, Torlapati G, Nicolet D, Mrózek K, Huang Y, Li A, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, Odenike O, Olin RL, Smith CC, Schiller GJ, Curran EK, Chan O, McMahon C, Hochman M, Sahasrabudhe K, Foucar C, Gonzalez-Lugo J, Knick Ragon B, Handa SV, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Borate UM, Mims AS, Eisfeld AK, Byrd JC, Madanat YF. Hoff FW, et al. Among authors: mims as. Am J Hematol. 2026 Sep;101(9):2246-2257. doi: 10.1002/ajh.70419. Epub 2026 Jul 2. Am J Hematol. 2026. PMID: 42393840 Free PMC article.
RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma.
Nadorp B, Lasry A, Loghavi S, Patel R, Mansour H, Rovatti PE, Kelly BJ, Walker CJ, Buss J, Boateng I, Al-Santli W, Ciantra Z, Austin R, Desai H, Abaza H, Procell L, Patel T, Kaffenberger B, Wijeratne S, Guillamot M, Velegraki M, Chiriboga LA, Li Z, Pollyea DA, McMahon CM, Shanaah A, Byrd JC, Esteller M, Papapetrou EP, Tsirigos A, Mims AS, Mardis ER, Aifantis I, Eisfeld AK. Nadorp B, et al. Among authors: mims as. Blood Cancer Discov. 2026 May 20. doi: 10.1158/2643-3230.BCD-26-0160. Online ahead of print. Blood Cancer Discov. 2026. PMID: 42160138
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Mohty R, Narra R, Mims AS, Hunter C, Shallis RM, Kota V, Jamy O, Coltoff A, Othman TA, Jonas BA, Patel AA, DuVall AS, Foucar CE, Abdelsamia M, Palmisiano N, Patel SA, Curran E, Omer Z, Advani A, Atallah E, Litzow MR, Badar T. Mohty R, et al. Among authors: mims as. Leuk Lymphoma. 2026 Jun;67(7):1587-1594. doi: 10.1080/10428194.2026.2650679. Epub 2026 Apr 9. Leuk Lymphoma. 2026. PMID: 41954351
Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report.
Zeidner JF, Jain J, Welkie RL, Huang Y, Swords RT, Traer E, Stein EM, Lin TL, Madanat YF, Collins RH, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, Odenike O, Olin RL, Smith CC, Foran JM, Schiller GJ, Curran EK, Handa S, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Mims AS, Byrd JC, Borate U. Zeidner JF, et al. Among authors: mims as. Blood Adv. 2026 Apr 14;10(7):2328-2332. doi: 10.1182/bloodadvances.2025019153. Blood Adv. 2026. PMID: 41632633 Free PMC article.
Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcoma.
Nadorp B, Lasry A, Loghavi S, Patel R, Mansour H, Kelly BJ, Walker CJ, Buss J, Boateng I, Al-Santli W, Ciantra Z, Austin R, Heyrosa A, Desai H, Laganson A, Abaza H, Procell L, Patel T, Kaffenberger B, Wijeratne S, Guillamot M, Velegraki M, Chiriboga L, Li Z, Abruzzo LV, Pollyea DA, McMahon C, Shana'ah A, Byrd JC, Shih A, Levine RL, Papapetrou EP, Tsirigos A, Mardis ER, Mims AS, Aifantis I, Eisfeld AK. Nadorp B, et al. Among authors: mims as. bioRxiv [Preprint]. 2025 Dec 5:2025.12.04.689069. doi: 10.64898/2025.12.04.689069. bioRxiv. 2025. PMID: 41573880 Free PMC article. Preprint.
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation Trial.
Handa S, Koenig K, Zhao Q, Mims AS, Vasu S, Garzon R, Haque T, Benson D, Klisovic RB, Marcucci G, Walker AR, Bhatnagar B. Handa S, et al. Among authors: mims as. Cancers (Basel). 2025 Dec 23;18(1):45. doi: 10.3390/cancers18010045. Cancers (Basel). 2025. PMID: 41514558 Free PMC article.
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML.
Jain J, Pugh K, Handa S, Dvorak-Kornaus KM, Zhao Q, Walter RB, Cook R, Saultz J, Swords R, Li J, Laszlo GS, Grieselhuber NR, Mims AS, Larkin KTM, Sahasrabudhe K, Blachly JS, Behbehani GK, Eisfeld AK, Long M, Srisuwananukorn A, Koenig KL, Borate U. Jain J, et al. Among authors: mims as. Blood Neoplasia. 2025 Oct 9;3(1):100171. doi: 10.1016/j.bneo.2025.100171. eCollection 2026 Feb. Blood Neoplasia. 2025. PMID: 41488889 Free PMC article. Clinical Trial.
88 results